StonvexLoading…
StonvexCore line items from NCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 |
|---|---|---|---|
Revenue | $25.14M | $25.53M | $32.45M |
Operating Income | $4.90M | $5.08M | $13.50M |
Net Income | $3.10M | $3.14M | $10.87M |
EPS (Diluted) | $0.10 | $0.10 | $0.40 |
Total Assets | $70.82M | $65.15M | Not available |
Total Liabilities | $45.99M | $54.21M | Not available |
Cash & Equivalents | $5.65M | $3.75M | $3.42M |
Free Cash Flow OCF − CapEx | $6.35M | $5.82M | $1.57M |
Shares Outstanding | 26.68M | 25.00M | 24.50M |